Prevention Genetics Logo
Test Code 10359
New York approved

Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) Panel

38 genes

2 - 3 weeks (7 - 16 days STAT)

Who is this test for?
  • Individuals with relevant features who have a clinical or suspected diagnosis of amyotrophic lateral sclerosis (ALS) and/or frontotemporal dementia (FTD) 
  • Individuals with a family history of ALS or FTD  
  • Individuals who tested negative for C9orf72 repeat expansion testing
Method
NGS with CNV (Exome or Genome Platform)
Specimen(s)

Exome Platform: Blood, DNA, Buccal, Saliva, Tissue

Genome Platform: Blood, DNA

Order Options

Platform
Test type
OTHER OPTIONS
for pricing.

Explore related tests

Questions? We can help.

Getting support has never been easier. Connect with our team for assistance with anything from test selection to interpreting results. Use the live chat button or visit our Contact us page.